KLRB1 and COVID-19: Together, we see an improved outcome in our HD cohort with less ICU admissions, which might be attributed to a chronic inflammatory state and increased frequencies of CD38+CD8+ memory and CD161+CD8+ T cells, both having a high cytotoxic activity to limit COVID-19 severity.